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ABSTRACT
Using Spatial Visualization Software to Influence Cancer Control Policy:
A Case Study of Prostate Cancer in South Carolina
by
Shannon Amelia Shropshire
Prostate Cancer in the United States shows great disparities among race and socioeconomic
status. Disparities in cancer rates in South Carolina are severe. Cancer control policies are
lacking in ways to identify reasons for high risk populations and cost-effective ways to do so. An
innovative spatial visualization program called the GeoViz Toolkit was used to determine areas
of high Prostate Cancer incidence and mortality in South Carolina (rates obtained from the South
Carolina Central Cancer Registry) compared with socioeconomic variables (education, income,
lack of health insurance, and living in rural areas) and race. From there, recommendations were
made using the South Carolina Cancer Alliance’s “South Carolina Comprehensive Cancer
Control Plan” objectives for Prostate Cancer for the top counties that were determined to have
the highest need of intervention. These 11 counties include Colleton, Hampton, Allendale,
Barnwell, Fairfield, Dillon, Marion, Marlboro, Williamsburg, Bamberg, and Orangeburg.

2

DEDICATION
I would like to dedicate this, and many other things in my life, to my grandmother, Clara
“Chris” Van Fleet. Grandma Chris, as she was always known to me and all of my friends, was
my guiding light for years and just recently passed away at 93. She constantly inspired me and
supported me through many life changing decisions. She was the reason that I ended up in East
Tennessee and in Public Health with a certificate in Gerontology. My entire life has been made
up of coincidences and by far the best one was that she was in my life. I recently realized that I
do not have many pictures of her around and decided that the reason for that was because she
was always there. I didn’t need a photo to remember her. She forgave me for my many
indiscretions and showed me the love that I so many times have forgotten how to give. She loved
knowledge and education and it fits that this will forever have her name.

3

ACKNOWLEDGEMENTS
I would like to thank my committee chair, Dr. Brian C. Martin, for all of your guidance.
All of your hard work is much appreciated and the timeliness in which it was accomplished.
Thanks to Drs. Roh and Florence for their support and friendship throughout the MPH program
and especially the thesis process. I’d like to thank Dr. Aldrich for the experience I’ve had in the
last two years. I learned so much working with you and greatly appreciate all the opportunities
that I have had. I’d like to thank Dr. Amal Khoury for your support. I’ve enjoyed working with
you this past year and appreciate all of your insight.
I would like to thank all of my friends who throughout this process continued to believe
in me, especially when I did not. Hally Turner, you are amazing and mean more to me than you
will ever know. Scott Sherburne, Cheryl Wolfe, Kim Wilson, and Wendy Woods-Whitson, thank
you for our times on the porch and always listening when I needed to vent. Greg Winters and
Jonathan Savoy, thank you for answering random questions, keeping me in line, and helping me
make deadlines. Taylor Hayes, thank you for being you and for understanding me.
I would like to thank Susan Bolick-Aldrich and Catishia Mosley at the South Carolina
Central Cancer Registry for providing the data and guidance that you did and always doing so
much faster than I thought possible.
I would like to thank Becky Wilkerson at the South Carolina Department of Health and
Environmental Control for her expertise in GIS and the timely manner in which you loaded my
data again and again, no questions asked.
I would like to thank the people I worked with at Penn State University throughout this
project for always answering my questions, even the simple ones, Dr. Eugene Lengerich and Dr.
Frank Hardisty.

4

I would like to thank my family for never being more than a phone call away and for
always being there. To my Dad, Lewis Shropshire, I would like to say thanks for always being
supportive, even when I made it hard. To my Mom, Susan Van Fleet, I want to thank you for
always caring the way you do and for pushing me to the next level. To my sisters, you are an
inspiration and I have big footsteps to fill.

5

CONTENTS
Page
ABSTRACT………………………………………………………………………....

2

DEDICATION……………………………………………………………………….

3

ACKNOLEDGEMENTS…………………………………………………………….

4

LIST OF FIGURES………………………………………………………………….

10

LIST OF TABLES…………………………………………………………………...

13

Chapter
1. INTRODUCTION…………………………………………………………….

14

2. REVIEW OF THE LITERATURE…………………………………………...

20

Geographic Information Systems……………………………………………

20

Prostate Cancer………………………………………………………………

22

Screening…………………………………………………………………

22

Incidence…………………………………………………………………

24

Mortality…………………………………………………………………

25

Costs……………………………………………………………………..

25

Treatment…………………………………………………………………

26

Stage………………………………………………………………………

27

Socioeconomic Status………………………………………………………..

27

Education…………………………………………………………………

28

Income……………………………………………………………………

28

Access…………………………………………………………………….

29

6

Rural………………………………………………………………………

29

Age……………………………………………………………………….……

30

Race…………………………………………………………………………...

30

Health Policy…………………………………………………………….……

32

3. METHODS………………………………………………………………..……

34

Research Questions………………………………...........................................

34

Independent Variables………………………………………………………..

34

Dependent Variables………………………………………………………….

35

Data…………………………………………………………………………...

35

The GeoViz Toolkit Applications…………………………………………….

36

South Carolina Comprehensive Cancer Control Plan…………………..…….

39

Data Analysis…………………………………………………………………

41

Confidentiality………………………………………………………………..

41

4. RESULTS……………………………………………………………………...

42

Maps…………………………………………………………………………..

42

Correlations……………………………………………………………….......

42

Education and Incidence……………………………………………………...

43

Poverty and Incidence………………………………………………………...

45

Health Insurance and Incidence………………………………………………

46

Rural Versus Urban and Incidence……………………………………………

47

African-American and Incidence……………………………………………..

48

Education and Mortality……………………………………………………...

49

Poverty and Mortality………………………………………………………...

49

7

Health Insurance and Mortality………………………………………………

50

Rural Versus Urban and Mortality……………………………………………

51

African-American and Mortality……………………………………………...

52

White Variables Only………………………………………………………...

53

Less Than a High School Education……………………………………...

54

Income Below the Poverty Line…………...……...………………………

54

African-American Variables Only……………………………………………

55

Less Than a High School Education……………………………………...

55

Income Below the Poverty Line…………...………...……………………

56

Screening Rates Compared to Mortality………………..…………………….

56

Incidence Compared with Mortality………………………………………….

57

Early-Stage Rates and Late-Stage Rates……………………………………...

58

All Independent Variables……………………………………………………

59

All Independent Variables with Incidence and Mortality…………………….

59

Consistent Counties……………………………………………………………

60

5. DISCUSSION………………………………………………………………….

62

Consistent Counties…………………………………………………………...

62

Correlations……………………………………………………………………

63

African-American Versus White………………...……………………………

64

Access Versus Screening...……………………………………………………

65

Late-Stage Incidence Versus Mortality...………………..……………………

65

Early Detection Objective 4 SCCA CA Plan ………..……………………….

65

Early Detection Objective 5 SCCA CA Plan…………………………………

66

8

Advocacy and Policy Objective 3 SCCA CA Plan…………………………...

66

Challenges………………………………………………………………….....

67

Overall Recommendations……………………………………………………

67

Benefits to Health Services Administration…………………………………..

67

Limitations of This Study……………..……………………………………...

68

Future Recommendations…………………………………………………….

68

6. CONCLUSION………………………………………………………………..

70

REFERENCES……………………………………………………………………....

71

APPENDICES……………………………………………………………………….

85

Appendix A: Coded Variables...………………………………………………….

85

Appendix B: Maps….…………………………………………………………….

86

VITA…………………………………………………………………………………

102

9

LIST OF FIGURES
Figure

Page

1. StarPlot with PrCa Rates……………………………………………………….

17

2. StarPlotMap with PrCa Rates and Urbana with African-American……………

18

3. StarPlot with Independent Variables…………………………………………...

37

4. ParallelPlot with Independent Variables……………………………………….

38

5. StarPlotMap with Independent Variables………………………………………

38

6. SingleScatterPlot with Infant Mortality Rates and Cancer Mortality…………..

39

7. SCCA Cancer Plan, October 2005, p. 26……………………………………….

40

8. SCCA Cancer Plan, October 2005, p. 35……………………………………….

40

9. SingleScatterPlot with Education and Total Incidence Rates...…….…………..

44

10. Late-Stage Incidence Rates with Education…...………...…………….……...

44

11. Total Incidence Rates with Poverty……………………...……………………

45

12. Total Incidence Rates with Health Insurance…………...…………………….

46

13. Total Incidence Rates with Rural Versus Urban…………………………...…

47

14. Early-Stage Incidence Rates with African-American…………………………

48

15. Mortality Rates with Education……..………………………………………...

49

16. Mortality Rates with Poverty……………………………….…………………

50

17. Mortality Rates with Health Insurance………………………………………..

51

18. Mortality Rates with Rural Versus Urban………………………………...…..

52

19. SingleScatterPlot with Mortality Rates and African-American………………

52

20. Mortality Rates with African-American………………………………………

53

10

21. Mortality Rates with 2001 Screening Rates.………………………………….

57

22. Mortality Rates with Late-Stage Incidence Rates…………………………….

58

23. Early-Stage Incidence Rates with Late-Stage Incidence Rates……………….

58

24. StarPlot with Independent Variables………………………………………….

59

25. StarPlotMap with Incidence and Mortality with Independent Variables……..

60

26. Consistent Counties…………………………………………………………...

62

27. Correlation Consistent Counties………………………………………………

63

28. Early-Stage Incidence Rates with Education………………………………….

86

29. Total Incidence Rates with Education………………………………………...

86

30. Early-Stage Incidence Rates with Poverty……………...…………………….

87

31. Late-Stage Incidence Rates with Poverty...…………………………………...

87

32. Early-Stage Incidence Rates with Health Insurance…………………………..

88

33. Late-Stage Incidence Rates with Health Insurance...……………...………….

88

34. Early-Stage Incidence Rates with Rural Versus Urban……………………….

89

35. Late-Stage Incidence Rates with Rural Versus Urban…...…………………...

89

36. Total Incidence Rates with African-American………………………………..

90

37. Late-Stage Incidence Rates with African-American…...……………………..

90

38. Mortality Rates with 150% of Poverty Line…………………………………..

91

39. White Total Incidence Rates with White Education………………...………...

91

40. White Early-Stage Incidence Rates with White Education……...……………

92

41. White Late-Stage Incidence Rates with White Education…………………….

92

42. White Mortality Rates with White Education………………………………...

93

43. White Total Incidence Rates with Poverty……………………………………

93

11

44. White Early-Stage Incidence Rates with Poverty……………………………..

94

45. White Late-Stage Incidence Rates with Poverty……………………………...

94

46. White Mortality Rates with White Poverty……...……………………...…….

95

47. African-American Total Incidence Rates with African-American Education..

95

48. African-American Early-Stage Incidence Rates with African-American
Education…………………………………………………………………….

96

49. African-American Late-Stage Incidence Rates with African-American
Education…………………………………………………………………….

96

50. African-American Mortality Rates with African-American
Education…………………………………………………………………….

97

51. African-American Total Incidence Rates with African-American
Poverty…………………….............................................................................

97

52. African-American Early-Stage Incidence Rates with African-American
Poverty……………………………………………………………………….

98

53. African-American Late-Stage Incidence Rates with African-American
Poverty……………………………………………………………………….

98

54. African-American Mortality Rates with African-American Poverty…...…….

99

55. Mortality Rates with 2002 Screening Rates…..………………………………

99

56. Mortality Rates and Early-Stage Incidence Rates……………………......…...

100

57. Mortality Rates and Late-Stage Incidence Rates……………………………...

100

58. African-American Education with 2001 Screening Rates…………………….

101

12

LIST OF TABLES
Table

Page

1. Correlation Values……………………………………………………………...

43

2. White Correlation Values………………………………………………………

54

3. African-American Correlation Values………………………………………….

55

4. Map Appearances………………………………………………………………

60

13

CHAPTER 1
INTRODUCTION
Prostate Cancer (PrCa) in the United States shows great disparities among race and
socioeconomic status. Disparities in cancer rates in South Carolina are severe (Drake et al.,
2006). Cancer control policies are lacking in ways to identify reasons for high risk populations
and cost-effective ways to do so. The use of new technologies will help to optimize cancer
control policy decisions with limited resources and in effect help to address the differences in
socioeconomic variables (Bezold, 2006). Growing and adapting to the problems and solutions in
the world is a crucial part of Public Health and is necessary to continue to serve the general
population. New technologies are a way of shifting with the times.
The GeoViz Toolkit is an exploratory spatial data visualization software program mostly
designed by Frank Hardisty at Penn State University. Others authored certain parts of the
program, their names and contributions can be found at http://code.google.com/p/geoviz/
wiki/GeoVizToolkitContributors. It is an application version of the GeoVista Studio found at
http://www.geovista.psu.edu/geoviztoolkit/main.html. Continuous development of the program
was funded through grant monies from the Centers for Disease Control and Prevention (CDC).
The initial intent of the program design was to compare the strengths and weaknesses of spatial
statistical methods for use by state-based Comprehensive Cancer Control (CCC) programs (CDC
Cooperative Agreement Funding Opportunities, n.d.). The program contains a plethora of
applications that can be used to analyze data including but not limited to histograms, scatter
plots, geomaps, star plots, parallel plots, and the ability to use SaTScan within the program.
SaTScan is another visualization tool that allows analysis of “spatial, temporal, and space-time
scan statistics” (SaTScan, 2005). The data must be entered into a shapefile using GIS software in
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order to upload the specific state map that allows for the analysis. The GeoViz Toolkit is
freeware that is being continuously updated and improved and available online at
http://www.geovista.psu.edu/grants/cdcesda/software/.
The mapping of epidemiologic data occurred at least as early as 1854 as John Snow
mapped the deaths of the London Cholera epidemic (Friendly, 2006). Today, the National
Cancer Institute provides data visualization resources on their website at
http://gis.cancer.gov/resources/visualization.html. Spatial visualization software such as the
GeoViz Toolkit can be used to help identify and therefore address disparities of PrCa in areas
with high incidence and mortality, especially in those areas with late stage diagnoses (Seidman,
2006). Identification of problem areas can lead cancer control programs to create specially
defined interventions in areas that were potentially unnoticed prior to the capabilities of such
software and many in the field recognize this advantage (Ghetian, Parrott, Volkman, &
Lengerich, 2008). In the identified areas in higher need of intervention, cancer control policies
can be implemented based on the socioeconomic variables that are lacking in that community.
Identifying those variables is merely the first step to a healthier community.
According to the 2007 United Health Foundations state rankings, South Carolina rests at
number 42, when number one is the healthiest state and number 50 is the unhealthiest. (United
Health Foundation, 2008). In 2004, PrCa had the highest incidence rate of new cancer diagnoses
in the state, 163.5 per 100,000 (Center for Disease Control and Prevention, 2007). This rate is
higher than the United States average by 18.2. The PrCa mortality rate in South Carolina is the
second highest (including cancers that kill both men and women) only behind Lung and
Bronchus Cancer, and is also above the national average by 7.2 per 100,000 (Center for Disease
Control and Prevention, 2007). CCC is a strong basis for combating cancer and the addition of
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spatial visualization software will increase the ability to do so (Ghetian et al., 2008). Hopefully,
the GeoViz Toolkit is the beginning of a new era and advisory committees around the country
will take notice of the possibilities that this type of analysis and prevention plan identification
and implementation could bring.
CCC is an emerging model for reducing cancer incidence, morbidity, and mortality
through prevention, early detection, treatment, rehabilitation, and palliation in hopes of
impacting the limited resources and achieving more desirable cancer prevention and control
outcomes (Center for Disease Control and Prevention, 2003). South Carolina has created a
Cancer Control Advisory Committee (SCCCAC) that is made up of South Carolinians who meet
three times a year to attempt to better the outcomes of cancer rates in the state. The committee is
made up of MDs, PhDs, MPHs, RNs, and others who serve the South Carolina health community
in one way or another. There are also task forces within the SCCCAC that are working on
specific cancers. The committee was created by South Carolina law and the members are
appointed by the Department of Health and Environmental Control (DHEC) Commissioner
(South Carolina Department of Health and Environmental Control, n.d.).
The importance of using new technologies such as the GeoViz Toolkit can only make a
time consuming process shorter, allowing faster, smarter, more efficient decisions about cancer
control policy. With quicker identification and more specialized interventions could come lower
rates of disparities between different races as well as different socioeconomic variables.
Using the GeoMap, StarPlotMap, SingleScatterPlot, and StarPlot applications, among
others, of the GeoViz Toolkit, determinations were made about which counties have a higher
need for intervention. These decisions were based upon socioeconomic (SES) information and
race combined with incidence, stage of diagnosis, and mortality rates. The color coded maps that
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the GeoViz Toolkit produces give a quick, easily determinable visual response to the question of
which counties have higher rates combined with whatever socioeconomic variable is being
considered. Figure 1 shows an example of the StarPlot tool. This example includes all races,
age-adjusted prostate cancer rates for total incidence, early- and late-stage, and mortality data.

Figure 1. StarPlot with PrCa Rates
In Figure 1, Orangeburg is the county with the largest combined magnitude of all four of
these variables. There are two ways of identifying the counties that would benefit most from an
intervention. One, they are ranked from lowest to highest in this chart. When using the program,
scrolling over each StarPlot reveals which county it is and what the rates are, shown where
Orangeburg is in Figure 1. Another way to judge is simply by visualizing which county appears
to have the largest StarPlot. This is more applicable in the StarPlotMap tool as seen in Figure 2.
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Figure 2. StarPlotMap with PrCa Rates and Urbana with African-American
Results from the GeoViz Toolkit analysis can be used to examine specific counties and suggest
plans to reduce incidence rates, especially late stage diagnoses and mortality rates.
A statistical program called SPSS (version 15.0) was also used to test for correlation
values for the SES variables being used. This part of the process determined which
socioeconomic variables or race were more likely associated with counties having higher rates of
prostate cancer incidence and mortality.
All of this information combined was used to make recommendations for possible future
steps in controlling PrCa in South Carolina. Some of the recommendations are based on the
2005-2010 South Carolina Cancer Alliance Cancer Control Plan. Further recommendations are
based on the results of this project.
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Pieces of this work have been presented at two different conferences. First, at the
Tennessee Public Health Association’s Conference in October of 2007 and then at the Council of
State and Territorial Epidemiologists Conference in June of 2008, both entitled “Visualizing
Socioeconomic Determinants of Prostate Cancer.”
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CHAPTER 2
REVIEW OF THE LITERATURE
Geographical Information Systems
Geographical information systems are an innovative way to enhance policy decisions.
Rushton (2003) predicts that more and more studies will incorporate GIS science into health
analyses. Public health has had a long history of cancer research and applying technological
advancements (Ghetian et al., 2008). Abe, Martin, and Roche (2006) used SaTScan to determine
areas of late stage PrCa in New Jersey adding that spatial analyses can increase ways to
determine areas of less favorable outcomes. Other authors suggest using visualization as a way to
determine patterns of incidence, late stage diagnoses, mortality, accessibility to care, spatiotemporal patterns, poverty, and environmental exposures among other uses (Drake et al., 2006;
Ghetian et al.; Marusek, Cockburn, Mills, & Ritz, 2006; Mather et al., 2006). Visualization in the
context of public health refers to the ability to map the disease data obtained and actually being
able to see where the areas of disparities are. Seeing where there are groups of counties with high
rates can be invaluable.
Bell, Hoskins, Pickle, and Wartenberg (2006) warn against using inappropriate maps in
presentations and making sure that the intended audience is capable of deciphering their
meaning. The GeoViz Toolkit is a complicated program and the starplots application, while
advantageous to the trained eye, may not initially make sense without a thorough explanation.
However, when presenting to public health officials and others in the field, this should not be
difficult. Brewer (2006) encourages using multiple maps in order to get the point across and
states that informative legend wording, color choices, symbol types, and suitable map projections
are keys to skilled mapmaking. Parrott, Hopfer, Ghetian, and Lengerich (2007) examined using
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maps as a communication form and reviewed the 36 available CCC plans for the presence of
maps. They found that only 14 state’s plans contained maps while 10 states had tools with which
queries could be done to map cancer incidence and mortality. Stage at diagnosis was rarely
available (Parrott et al.). Stage is one of the major dependent variables being considered in this
study.
Bhowmick, Griffin, MacEachren, Kluhsman, and Lengerich (2008) assessed favorably
the willingness of Public Health officials to use geospatial software, yet Ghetian et al. (2008)
state that the use of GIS in cancer control efforts is unevenly employed. Many state CCC
programs perceive a need for more training in GIS, and only half of the state CCC directors
currently had access to geocoded data (Hopfer, Chadwick, Parrott, Ghetian, & Lengerich, 2008).
The GeoViz Toolkit is an attempt by the CDC to get all of the CCC programs on the same page.
Anselin (2006) advises ways not to lie with spatial statistics. There are many limitations
such as rare occurrences, counties with higher proportions of older men, etc. that depending on
how they are analyzed can yield different results. “When it comes to policy, spatial statistical
analyses are only a means, and not the end” (Anselin, p. 3). The author also talks about the
continuously changing technological advances and how it is hard to determine best practices, but
with clearinghouses and access to other experts through the internet many of these hurdles can be
overcome. Sharing results through a Web portal was another idea to increase the understanding
of GIS and the ability of colleagues to work together (MacEachren, Gahegan, & Pike, 2004).
Marusek et al. (2006) suggest that when looking at environmental exposures, taking into
account complete residential histories is important. The data that are being used in this study,
collected by the South Carolina Central Cancer Registry, only identify the person’s county of
residence at the time of diagnosis. Granted this study is not looking at environmental exposures,

21

but Drake et al. (2006) did suggest that South Carolina would be a good place to do so due to the
presence of soil selenium and cadmium concentrations, which affect prostate metabolism, in
rural areas where more African Americans tend to live. Xiao, Gwede, Kiros, and Milla (2007)
also analyzed environmental data and found racial and geographic disparities.
Several clusters of elevated risks of PrCa mortality were determined using a spatial scan
statistic for 506 state economic areas (Jemal, Devesa, Kulldorff, Hayes, & Fraumeni, 2000). The
largest risk for African-American (AA) men was in the South Atlantic area, but no
socioeconomic characteristics could be attributed to this group and further study is suggested
(Jemal, Kulldorff, Devesa, Hayes & Fraumeni, 2002). An in-depth look at several SES variables
in South Carolina is part of this study.
Prostate Cancer
Screening
Much debate has occurred regarding PrCa screening. Inevitably, when there is a huge
initial push for testing incidence rates rise drastically, and it is still uncertain whether mortality
decreases with increased screening (Albertsen, 2005; Di Matteo & Di Matteo, 2005; Yasunaga,
Ide, Imamura, & Ohe, 2006). Albertsen (2006) also questions whether or not PrCa should be a
public health concern because many men diagnosed are unlikely to survive another 10 years due
to age of diagnosis, suggesting that screening over a certain age is futile. While screening does
not cause any harm, the treatment that follows a diagnosis does. The author cites the results of
the Prostate Cancer Outcomes Study as a reason for physicians to caution their patients regarding
changes in quality of life after treatment, where 60% were impotent and 8% were incontinent
within 18 months of surgery (Albertsen, 2006).
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On a similar note, the United States Preventive Services Task Force issues
recommendations regarding screening for different types of diseases. As of 2002, PrCa is rated
an “I,” which means that there is not enough sufficient information for the Task Force to make a
recommendation. Their rationale is as follows:
“The USPSTF found good evidence that PSA screening can detect
early-stage prostate cancer but mixed and inconclusive evidence
that early detection improves health outcomes. Screening is
associated with important harms, including frequent false-positive
results and unnecessary anxiety, biopsies, and potential
complications of treatment of some cancers that may never have
affected a patient’s health. The USPSTF concludes that evidence is
insufficient to determine whether the benefits outweigh the harms
for a screened population” (Agency for Healthcare Research and
Quality, 2002).
Ekwueme, Stroud, and Chen (2007) cite the cost of testing as a concern for public health
officials due to limited resources and the uncertainty of the overall benefit. Krahn et al. (1994)
analyzed the costs of three types of tests for PrCa and determined that screening asymptomatic
men is not advisable because it may decrease health outcomes and increase the financial burden.
Makinen et al. (2002) determined that men with relatives who have had PrCa did not have a
higher risk of the disease and selective screening would have missed 94% of cancer cases in their
study. Multiple risk factors must be considered along with areas of high prevalence when
determining a solution. This is merely another example that there is no simple answer to
formulating ways to economically screen.
Mariotto, Etzioni, Krapcho, and Feuer (2007) assessed the frequencies at which white
and AA males began PSA testing when it first became available. They determined that older
white males tested earlier as did younger AA males indicating similar patterns overall and
concluded that racial factors were not a reason behind the differences in PrCa.
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In an attempt to access the willingness of a population to accept a cancer screening
policy, Paul, Nicholls, Priest, and McGee (2008) surveyed a group of women in New Zealand
about breast cancer. After being well informed about the disease, the screening process, and the
costs, all but one woman voted against a governmental policy for screening. These results
question how forceful policy makers should be regarding the health of the people they serve.
Testing should be available to everyone who wants it, but information regarding the benefits and
consequences are just as, if not more, important. Refusal of treatment to well-informed men is
not an option, especially when they know the risk of potentially experiencing more harm that
good (Schroder, 2005). Yasunaga et al. (2006) hypothesized that better education about the
screening process would reduce the desire for testing. Health education will be strongly
considered in the possibilities for interventions.
Phillips et al. (2004) considered the gatekeeper requirements of insurance policies and
their association with screening use. While for several female cancers they found that
gatekeepers were beneficial and increased screening rates, this was not the case for PrCa. The
authors do encourage policy makers to consider the gatekeeper when making public health
decisions.
Rogerson, Sinha, and Han (2006) analyzed spatial-temporal tends in PrCa mortality and
suggest that declines in Florida and Southern California may be due to realized beneficial results
of screening programs. Obviously, there is still much dissent between whether or not widespread
screening is advantageous or not.
Incidence
As previously stated, a rise in PrCa screening will increase the incidence rates (Albertsen
et al., 2005). While incidence data are certainly important, this study initially put much more
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emphasis on mortality and late-stage diagnosis. This is because all men who live long enough
will have some elevated level of prostate-specific antigen (Bostwick et al, 2004). Higher PrCa
incidence is not necessarily associated with higher risk factors and poorer outcomes (Gilligan,
2005).
Mortality
The National Cancer Institute estimates that in 2008, 28,660 men will die from PrCa
(National Cancer Institute, n.d.). In South Carolina, the 2008 estimate of new cases of PrCa is
2,520 and over 400 deaths (American Cancer Society, 2008). Jemal et al. (2000) found PrCa
mortality to be elevated in the Southeast region. PrCa mortality should be a high priority, and in
this study it will be considered as one of the main dependent variables. Higher mortality is
associated with lower SES (Vinnakota & Lam, 2006), while incidence rates are not similarly
associated (Gilligan, 2005). Higher mortality rates are also associated with being AA (Davey
Smith, Neaton, Wentworth, Stamler, & Stamler, 1998; Godley et al., 2003; Howard, Anderson,
Russell, Howard, & Burke, 2000). Access to health care can also affect the survival likelihood
(Greenwald & Henke, 1992).
Costs
Chang et al. (2004) estimated the costs of cancer from national surveys and federal
databases for 1999-2000. The costs for seven cancers, which include direct and indirect, were
estimated by these authors to be $60.9 billion and $15.5 billion respectively (Chang et al.). In
California, Max et al. (1998) estimated the direct costs and costs of lost productivity due to
premature death only from PrCa to both equal $180 million; therefore, the total being $360
million for 1998 alone. Prostate cancer’s mean monthly costs were $2,187 (Chang et al.).
Yabroff, Warren, and Brown (2007) found that costs were generally higher in the first year after
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diagnosis and the last year of life. In 2001, Benoit, Gronberg, and Naslund attempted to estimate
the cost per year of life saved with various types of screening and for different age groups. For
PSA screening alone, for men aged 50-70, the cost was $3822-$4956 per year. Using both PSA
and DRE screening for men aged 50-59 the cost was less at $2339-$3005 (Benoit et al.).
Ekwueme et al. (2007) estimated the resource costs of screening, including physician’s time,
patients time away from work, and laboratory costs. For PSA screening, the cost in the U.S. was
more than in other industrialized countries at a value of $37.23, but DRE screening was less than
in other industrialized countries and valued at $31.77 (Ekwueme et al.). “Society must decide if
the years of life saved in these men warrants the use of its limited health care resources” (Benoit
& Naslund, 1997a, p. 1533).
There is much debate about whether or not PrCa screening is cost effective or not; Benoit
et al. (2001) claim that it is. However, in a previous article by two of the same authors, they warn
that men aged 50-70 may not reap the benefits of screening till they are in their 80s (Benoit &
Naslund, 1997b). Krahn et al. (1994) found that screening with PSA did increase life expectancy
but decreased quality-adjusted life expectancy and do not recommend screening asymptomatic
men as all programs increase costs.
Treatment
Treatment of earlier stages of PrCa is more expensive than treatment of later stages
(Benoit & Naslund, 1997b). Godley et al. (2003) considered AA versus white survival rates
regarding three different types of treatments: (1) surgery, (2) radiation therapy, and (3)
nonaggressive treatment. African-American patients had a lesser median survival time than
whites for each type of treatment: 1.8 years less for surgery, .7 of a year less for radiation
therapy, and 1 year less for nonaggressive treatment (Godley et al., 2003). Greenwald and Henke
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(1992) compared treatment based on fee for service providers and health maintenance
organizations. Over a 20-year period considered by Hall, Holman, Wisniewski, and Semmens
(2005) in a study done in Australia, radical prostatectomy increased from 3.1% to 20.1%, while
non-radical treatment including transurethral, open or closed prostatectomy decreased by half.
Treatment outcomes are an important part of any cancer screening process; however, this study
does not include data regarding such outcomes.
Stage
Areas with large concentrations of late stage diagnoses are particularly important due to
the lesser survival rates (Abe et al., 2006). Conlisk, Lengerich, Demark-Wahnefried, Schildkraut,
and Aldrich (1999) state that, for diagnoses of PrCa, stage is one of the most determining factors
of mortality. They found income and health insurance status to be inversely correlated with a late
stage diagnosis for AA males, but not for whites (Conlisk et al.). Jemal et al. (2005) found
correlations between late-stage incidence and mortality in both white and AA males (r=.38 and
r=.53 respectively). Du et al. (2006) determined that survival of either stage was largely
determined by SES. African-American men tend to be diagnosed at later stages of PrCa (Sarma
et al., 2006). While both early and late stage data were received for this study, only late
(regional/distant) stage will be a primary concern and a dependent variable.
Socioeconomic Status
Socioeconomic status has many variables. The following are the topics that were found to
be most valuable in the evaluation of PrCa within other literature. Lower SES is associated with
early mortality (Du et al. 2006; Howard et al., 2000).
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Education
Several authors cite being less educated as a possible risk for higher mortality in PrCa
(Abe et al., 2006; Albano et al., 2007; Ndubuisi, Kofie, Andoh, & Schwartz, 1995; Talcott et al.,
2007; Vinnakota & Lam, 2006). Albano et al. found that AA men with less than a high school
education were twice as likely to die from PrCa as AA men with more than a high school
education. Dale, Vijayakumar, Lawlor, and Merrell (1996) reviewed 21 studies regarding PrCa
and socioeconomic variables and suggest that at least income and education should be used. This
study will consider educational levels as an independent variable at less than a high school
education compared to those with more than a high school education.
Income
The poverty level as defined by the Census bureau in 2000 was $17,050 for the 48
contiguous states for a family of four (U.S. Department of Health and Human Services, 2000).
Persons who live in poverty are more likely to have higher rates of mortality (Abe et al., 2006).
Winkleby and Cubbin (2003) found that cancer mortality was higher for those with lower
incomes across gender and the six racial and ethnic groups they studied. Bradley, Given, and
Roberts (2001) concluded that if cancer control programs continue to advance, focus areas
should include early detection for the poor. Wilkinson, List, Sinner, Dai, and Chodak (2003)
assessed if education about PrCa would change the awareness of African American men in
Illinois; higher income was associated with higher scores both before and after. Many authors
used income as a determinant of SES along with several other factors in regards to PrCa (Dale et
al., 1996; Davey Smith et al., 1998; Di Matteo & Di Matteo, 2005; Freeman, Durazo-Arvizu,
Arozullah, & Keys, 2003; Gilligan, Wang, Levin, Kantoff, & Avorn, 2004; Howard et al., 2000;
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Kim, Eby, & Piette, 2005; Ndubuisi et al., 1995; Talcott et al., 2007). This study will consider
persons below the poverty line, and persons within 150% of the poverty line.
Access
Persons living in more rural counties face a lack of health care services such as hospital
closings and less rural health departments and are more likely not to have health insurance
(Drake et al., 2006). Access also influenced the type of treatment received. Greenwald and
Henke (1992) found that “HMO patients were less likely to receive surgery but more likely to
receive radiation therapy than those in fee-for service settings” (p. 1099). Hall et al. (2005) found
that being admitted to a rural hospital in Australia increased the 3-year mortality rate and a lack
of health care insurance increased that possibility.
Jemal et al. (2005) assessed access to medical care based on the incidence of late-stage
disease. The authors conclude that “10% to 30% of the geographic variation in mortality rates
may relate to variations in access to medical care” (p. 590). The disparity between those with
health insurance coverage and those without, or those without a usual source of care physician is
growing (Swan, Breen, Coates, Rimer, & Lee, 2003). McDavid, Tucker, Sloggett, and Coleman.
(2003) found a 15% difference in three year relative survival based on those privately insured
versus the uninsured. Access in this study will be measured by a lack of health insurance.
Rural
Much of South Carolina’s African American population resides in rural areas of the state,
where they are more likely to live in poverty, report lower health status, and be lacking in health
insurance coverage (Drake et al., 2006). Hall et al. (2005) considered several factors including
geographical effects on 3-year survival in Australia. They found that those admitted to rural
hospitals had a higher 3-year mortality rate than those admitted to urban hospitals (Hall et al.).
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Non-metro counties were found to have greater levels of late-stage diagnosis as well as mortality
(Jemal et al., 2005). From 1950-2000, mortality rates were higher in rural counties in the
Northern Plain states when considering crop patterns and PrCa (Rusiecki, Kulldorff, Nuckols,
Song, & Ward, 2006). Whether an area is urban or rural will be taken into consideration during
this study.
Age
The nature of PrCa is that any man who lives long enough is likely to have an increased
level of prostate-specific antigen (PSA). Freeman et al. (2003) looked at comparisons between
Veterans Affairs (VA) and private sector health systems and determined that only in the private
sector was age an increased risk for mortality. Gilligan et al. (2004) considered racial screening
rates in the elderly, determining that AA Medicare recipients were noticeably less likely to
undergo screening. Mariotto et al. (2007) found similar results for white males over age 60.
Powell, Schwartz, and Hussain (1995) determined that for men in the VA system survival rates
for whites were greater for those under age 70, but AA men over age 70 were more likely to have
lower mortality. Annual income, age, and hospitalization history were likely to increase the
willingness to pay for PrCa screening in Japanese men aged 40-59 (Yasunaga et al., 2006).
Many studies controlled for age (Albano et al., 2007; Davey Smith et al., 1998; Delfino
Ferrini, Taylor, Howe, & Anton-Culver, 1998; Du et al., 2006; Kim et al., 2005; Krieger et al.,
1999; Mather et al., 2006). Because the rates considered in this study are age-adjusted, age will
not be one of the independent variables being taken into account for this study.
Race
“Understanding the causes of the high prostate cancer mortality seen among black men
remains the major challenge in the area of social disparities and prostate cancer” (Gilligan, 2005,
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p. 45). Racial disparities are always a subject of concern in public health, especially within
diseases where a certain race consistently has higher rates. South Carolina PrCa rates fall into
this category. African-American men routinely are diagnosed at later stages of disease, have
higher rates of overall incidence, and higher rates of mortality (Gilligan; Godley et al., 2003;
Jemal et al., 2006; Ndubuisi et al., 1995; Powell et al., 1995; Sarma et al., 2006; Talcott et al.,
2007). Jemal et al. (2002) found that for AA men there was a cluster of higher PrCa rates in the
South Atlantic area.
In the District of Columbia, AA patients are younger and their tumors appear to be more
aggressive (Ndubuisi et al., 1995). However, Powell et al. (1995) found a crossover effect; AA
men over age 70 appear to have higher survival rates.
In a study done by Bradley, Clement, and Lin (2008), AA men were less likely to receive
surgery. Cohen et al. (2006) established that AA men had a 13-month less disease-free survival
time than whites. In the same study, Asian men had the longest disease-free survival time, 26
months longer than whites, with Hispanic men having the second longest at 16 months (Cohen et
al.). Godley et al. (2003) also found that AA men had lower median survival times after
treatment as well.
Conlisk et al. (1999) found health insurance and income to be inversely correlated with
stage in AA men, but these factors were not associated with white men. Dale et al. (1996) could
not conclude that racial differences between AAs and whites were based solely on race or if SES
factors were more responsible. Davey Smith et al. (1998) studied the differences in risk factors
for AAs and whites. When they controlled for income, the differences were greatly reduced, and
other adjustments did not alter the risk. Howard et al. (2000) found that SES accounted for much
of the earlier mortality for AA men; however, this was not the case for PrCa.
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Men who have family members with a previous history of PrCa are more likely to have
the disease themselves. Drake, Lathan, Okechukwu, and Bennett (2008) found that AA men in
South Carolina who have a family history are not more likely to be tested. Gilligan et al. (2004)
determined that AA race is a strong predictor of whether or not elderly men have PSA screening
tests. Mariotto et al. (2007) used a model simulation to attempt to explain racial adoption of PSA
testing. According to their results, testing did not make a major difference in the mortality rates
and declines. However, by their own admission, retrospective data sources have their limitations
(Mariotto et al.).
Sarma et al. (2006) looked at AA men’s PrCa and the relationship with sexual behavior
and sexually transmitted diseases. They found that men who reportedly had 25 or more partners
were 2.8 times more likely to get cancer than men who had had fewer than five partners (Sarma
et al.). “African American men acknowledged their greater risk of Prostate Cancer, accepted
greater responsibility for their health and reported more personal failures that delayed diagnosis”
(Talcott et al., 2007, p. 1599).
Health Policy
Policy is an important part of addressing health disparities. Understanding the risk factors
of PrCa can have a direct impact on policy (Bostwick et al., 2004). There is also an inverse
relationship where policy has an impact. The National Cancer Institute is an example, where
there is a Congressional mandate for public dissemination of health information (Croker et al.,
2004). Cancer control managers recognize the policy implications that come with the ability to
map PrCa and know the need for updated applications (Ghetian et al., 2008).
Dobrow, Goel, Lemieux-Charles, and Black (2006) examined how policy makers in
Ontario used evidence-based decision making and concluded that the challenge was to link broad
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interpretations of evidence to the appropriate policy questions, all the while keeping in mind the
policy objectives. Drake et al. (2006) stress using community-based participatory research in
advancing health policy and suggest that perhaps the current PrCa screening material is not
appropriate for the South Carolina population. The same authors also mention that in South
Carolina unequal weight is given to breast and cervical cancer screening, where no extra funding
is provided by law to PrCa screening (Drake et al., 2006).
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CHAPTER 3
METHODS
There were several methods used for this study. Certain research questions were explored
based upon county level variables of socioeconomic status and race compared with incidence
and mortality data for PrCa in South Carolina. This chapter explains the variables, where they
were obtained, the software package used, the South Carolina Cancer Control Plan, how the data
were analyzed, and how confidentiality was maintained.
Research Questions
1. How do the independent variables affect the dependent variables?
2. How do the dependent variables vary with each other?
Independent Variables
The independent variables used to answer the research questions of this study are based
on reviews of the literature as well as variables that were accessible. These variables include:
education, income, health insurance, rural areas, screening rates, infant mortality rates and race.
See Appendix A for how the variables are coded.
The variable used to address education is a percentage of persons over the age of 24,
residing in a county who have less than a high school education. Two income variables were
used. One is the percentage of persons living in a county under the poverty line. In 2000, the
midline for the years the data was collected, the poverty line was $8,350 for one person (U.S.
Department of Health and Human Services, 2008). The second variable used is the percentage of
persons living within 150% of the poverty line. Health insurance is an indicator of access to
health care. In this study it is the percentage of persons living in a county without health
insurance.
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The variable used to assess the extent to which a county is considered rural is called
URBANA. This variable will be different from the others because low areas of this variable will
be more telling than high areas like the rest of the variables. Because AA men have some of the
highest incidence and mortality rates of PrCa, the race variable is the percentage of persons
residing in a county who are AA.
Dependent Variables
While all incidence rates will be considered, the two main dependent variables will be the
age-adjusted rate per county of men diagnosed with late-stage PrCa and the age-adjusted PrCa
mortality rate per county. The other two incidence rates are: age-adjusted rates of early-state
PrCa and age-adjusted total incidence rates. Race-specific variables will also be considered for
both AA and white.
Data
The cancer data, from 1997-2003, were obtained from the South Carolina Central Cancer
Registry. These include: county level incidence rates for PrCa, both early and late stage, county
level mortality rates for PrCa, and incidence and mortality rates for all types of cancer at the
county level. The South Carolina Central Cancer Registry (SCCCR) collects data from hospitals
on all types of cancer. The SCCCR was created in 1996 and has since been nationally recognized
several times as a gold level rating through the North American Association of Central Cancer
Registries and the Centers for Disease Control and Prevention (Vena, 2006, p. 175).
The SES variables including: LTHSEDA, PLTCPOVA, PLTCVPOVA, URBANA, and
BLACK, as well as others not used in this evaluation, were obtained through a previous project
with Penn State University. They were assembled from the County Attributes file from the
SEER*Stat program which is calculated using the 2000 Census.
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Health insurance coverage percentages and Medicare enrollment percentages were
obtained at the county level from the South Carolina Community Profiles webpage at
http://www.sccommunityprofiles.org/index.asp. This website is sponsored by the United Way of
South Carolina, the South Carolina Budget and Control Board, and the Sisters of Charity
Foundation of South Carolina. The data on this website focus on demographic and economic
data from the U.S. Census at the state, county, zipcode, and census tract levels.
PrCa Screening rates for 2001 were retrieved from the South Carolina Department of
Health and Environmental Control website under their Behavioral Risk Factor Surveillance
System data at http://www.scdhec.gov/hs/epidata/BRFSS/psatest.html. One issue with these rates
is that they are only listed by region. Therefore, depending on the size of the region, up to seven
counties will have the same percentage of screening rates. Another issue with these rates is the
small number of persons surveyed. For this question, only 689 men responded to the survey
(South Carolina Department of Health and Environmental Control, 2003).
Infant mortality rates were obtained from the South Carolina Department of Health and
Environmental Control’s website from a report entitled “Infant Mortality and Selected Birth
Characteristics: 2001 South Carolina Residence Data” for the 1999-2001 rates. These rates are
calculated for three years since they are more stable and more representative than one single
year. However, rates were also considered for only the year 2000 obtained from the same
website in a report similarly titled only for 2000 instead of 2001.
The GeoViz Toolkit Applications
The GeoViz Toolkit has numerous applications. Only a few tools, VariablePicker,
SpreadSheetBean, StarPlot, ParallelPlot, GeoMap, StarPlotMap, and SingleScatterPlot, were
used in this study. To analyze the previous research questions the key variables were input into a
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shapefile and then uploaded into the GeoViz Toolkit. A shapefile can be created with GIS
software such as ArcGis. They are saved as a collection of files that must all be present to be
usable, six in this case. Shapefiles store geographic and attribute information (U.S. Geological
Survey, 2008).
VariablePicker, StarPlot, GeoMap, and StarPlotMap are default settings and immediately
show on the screen when the shapefile is loaded. VariablePicker shows all of the variables that
are included in the uploaded shapefile. The user selects the variables to be considered and hits
send selection. The SpreadSheetBean allows the user to see not only all of the variables input but
the actual values as if in a spread sheet. StarPlot is a visualization tool where each variable
selected is represented proportionally within the circle. The lines extending from the center of
each circle represents a different variable. For example, Allendale County is highlighted in
Figure 3 and has the highest percentages of all South Carolina Counties of no health insurance,
less than a high school education, people living below the poverty line, and people who live in
the county who are AA.

Figure 3. StarPlot with Independent Variables
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Because each variable is proportionately represented in the StarPlot, four of five of the lines in
the Allendale County StarPlot are touching the outside of the circle. This is interpreted to mean
that for those four variables Allendale County has the highest percentages of all 46 counties.
The ParallelPlot tool is similar only showing from smallest to largest within each
variable. Figure 4 is an example. As the user scrolls across the lines, the county is highlighted.

Figure 4. ParallelPlot with Independent Variables
Again, Allendale County is the example.
The GeoMap is a bivariate map that allows the user to visualize areas that have high rates
in two areas being considered shown in Figure 5. The user may choose the colors being used.
These can be seen in the data
analysis section. The StarPlotMap
is a combination of the StarPlot tool
and the GeoMap tool. In Figure 5,
the colors on the map represent
PrCa incidence rates compared with
Figure 5. StarPlotMap with Independent Variables
38

mortality rates. The areas that are more darkly shaded are the areas that have high rates of both.
The StarPlots overlap the county whose information they represent. The variables are the same
as those represented above.
The SingleScatterPlot function can be used to determine correlation as well as provide a
visualization to easily determine outliers. Figure 6 shows that age-adjusted all cancer mortality is
positively associated with infant mortality rates for 1999-2000.

Figure 6. SingleScatterPlot with Infant Mortality Rates and Cancer Mortality
Several of the other functions of the GeoViz Toolkit include a variable transformer,
histograms, link graphs, an animator, Moran’s map and the ability to incorporate SaTScan, along
with others, but these were not used in this analysis.
South Carolina Comprehensive Cancer Control Plan
An assessment was made as to which counties have the greatest need regarding public
health intervention. Once these areas were determined, recommendations were made, based on
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the SC Cancer Control Plan objectives for 2005-2010 and previous research presented in the
literature, in order to help decrease the disparities.
The South Carolina Cancer Alliance created a Cancer Control Plan for 2005-2010 based
on the 2004 Cancer Report Card (South Carolina Department of Health and Environmental
Control, 2004). There are three objectives within the plan pertaining to PrCa, Objectives four and
five under the Health Disparities section and Early Detection subsection, and Objective 3 under
the Advocacy and Policy section. The recommendations that follow in this study are based on
these objectives and the strategies that follow in Figure 7 and Figure 8.
Early Detection:

Figure 7. SCCA Cancer Plan, October 2005, p. 26
Advocacy and Policy:

Figure 8. SCCA Cancer Plan, October 2005, p. 35
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Data Analysis
Each of the independent variables was examined compared to each dependent variable
using SPSS to determine correlation values (two-tailed) and statistical significance, p-values of
less than .05. Each independent variable was also examined compared with each dependent
variable in the GeoViz Toolkit. The GeoViz Toolkit offers the user several ways of looking at
the same thing. Which component is used depends on the user’s point of view and analytical
ability to see things. The counties with the highest rates of both variables were determined per
research question using standard deviation for all except the rural versus urban question, in
which case quartiles were used. An overall comparison of all independent variables and
dependent variables was completed using the GeoViz Toolkit and determinations were made
based on the StatPlotMap tool about which counties were in the most need of help.
Confidentiality
Persons whose information was obtained for this study remain anonymous. The data
collected from the SCCCR are on an individual level, but rates are suppressed under a certain
number in order to prevent any possibility of determining who has a certain disease. In this
study, all of the information is at a county level and there is no possibility of identifying
individuals.
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CHAPTER 4
RESULTS
Each independent variable was considered compared with each dependent variable.
Using the GeoMap tool in the GeoViz Toolkit, maps were created to show which counties have
high rates of both variables being considered. Correlations were calculated for all variables. The
StarPlot tool was used to compare all of the independent variables together and the StarPlot Map
was used to compare all of the independent variables with incidence and mortality.
Maps
All of the maps in this section were made using the GeoViz Toolkit. For the bivariate
maps the colors used are red and blue. The higher the rates of both of the variables being
considered the darker the color will be. Choosing to use red and blue will therefore make the
areas of highest concern purple. Two standard deviations are used as the distributing factor.
Some variables have to be considered differently due to the nature of the variable, but the maps
follow the previously stated format unless otherwise noted.
Correlations
Using SPSS to determine the correlation values and test for significance shows that none
of the SES variables are statistically significant when it comes to predicting early- or late-stage
incidence at the time of diagnosis. Counties with high percentages of AAs are positively
correlated with early- and late-stage incidence, but only early-stage incidence is significant at a p
value of .028. It is the closest to being statistically significant when relating to late-stage
diagnoses, but that is only at a p value of .059. On the other hand, every variable being
considered is significant in predicting mortality rates.
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The correlation values are shown in Table 1 for early and late stage diagnosis, total
incidence, as well as mortality.
Table 1.
Correlation Values
N=46
Less Than a
HS Education
Income Below
the Poverty
Line
No Health
Insurance
Urban

AfricanAmerican

Pearson
Correlation
Significance
Pearson
Correlation

Early-Stage
Incidence

Late-Stage
Incidence

Total
Incidence

Mortality

-.097

.099

-.006

.458(*)

.522

.514

.971

.001

.261

.231

.362(*)

.640(*)

Significance
.080
.123
.013
Pearson
.165
.096
.340(*)
Correlation
Significance
.272
.526
.021
Pearson
-.229
-.021
-.164
Correlation
Significance
.126
.888
.277
Pearson
.323(*)
.280
.403(*)
Correlation
Significance
.028
.059
.006
* indicates statistical significance at a value of p<.05

.000
.622(*)
.000
-.316(*)
.032
.728(*)
.000

Education and Incidence
Less than a high school education does not appear to be a very good predictor of
incidence. For late-stage diagnoses it is positively correlated, but only at .099 and not significant
at p=.514. For early-stage incidence and total incidence it is actually negatively correlated,
showing that persons with more education are diagnosed sooner, but neither of those values are
significant. Overall incidence is the least significant of all the variables being considered at a
correlation value of -.006, and a p value of .971. Basically, it shows no correlation at all as can
be seen by the almost horizontal line in Figure 9.
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Figure 9. SingleScatterPlot with Education and Total Incidence Rates
Figure 10 shows the counties with late stage diagnosis and high rates of persons with less
than a high school education in purple.

Figure 10. Late-Stage Incidence Rates with Education
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The counties shown in Figure 10 are Cherokee, Union, Chester, Fairfield, Laurens, Abbeville,
McCormick, Lee, Marion, Williamsburg, Jasper, Colleton, Bamberg, Barnwell, and Allendale.
Maps for early-stage diagnosis and total incidence can be found in Figures 28 and 29 in
Appendix B.
Poverty and Incidence
Late-stage diagnosis is also correlated with persons below the poverty level; however, it
is not significant for early or late stage. Total incidence is highly correlated and at a statistically
significant level. Figure 11 shows total incidence with persons living below the poverty line.

Figure 11. Total Incidence Rates with Poverty
Fairfield, Marlboro, Dillon, Williamsburg, Georgetown, Orangeburg, Barnwell, Bamberg,
Allendale, Hampton, and Colleton counties have the higher rates. Early- and late-state incidence
rates compared with poverty can be found in Appendix B in Figures 30 and 31.
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Health Insurance and Incidence
The lack of health insurance is not a very positive predictor of late stage incidence at a
correlation value of .096. Neither stage is statistically significant with values of .272 and .526
respectively. Overall incidence and a lack of health insurance are significant at a correlation
value of .340 and a p value of .021.
Barnwell, Bamberg, Orangeburg, Colleton, Allendale, Hampton, Williamsburg,
Georgetown, Dillon, and Marlboro are the counties highlighted in Figure 12 that have high rates
of both high total incidence rates and high rates of no health insurance. Early- and late-stage
incidence rates with health insurance can be found in Figures 32 and 33 in Appendix B.

Figure 12. Total Incidence Rates with Health Insurance
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Rural Versus Urban and Incidence
Persons living in counties that are more rural than urban are more likely to be diagnosed
with PrCa. However, no correlation value is significant for this variable: overall incidence, earlyor late-stages. Late-stage incidence considered with the urban variable has the second lowest
correlation value of any of the variables considered and listed in Table 1 with a predictive value
of -.021, therefore, also with the second highest p value making this comparison extremely
insignificant.
Figure 13 is different than the other maps due to the nature of this variable. In this case,
counties that are the darkest blue with no shades of red are the important ones.

Figure 13. Total Incidence Rates with Rural Versus Urban
This variable measures the percent of urban population per county, while the percent of rural
population is what is being considered in this research question. This map is also different in that
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it is measured in quartiles rather than by standard deviation because we are looking at the
opposite of the variable input into the GeoViz Toolkit. Fairfield and Williamsburg are the only
two for total incidence. Early- and late-stage with health insurance can be found in Appendix B
in Figures 34 and 35.
African-American and Incidence
Figure 14 is a bivariate map of early-stage incidence of PrCa and the percentage of AA
persons per county. The darker purple counties are areas of concern and are highlighted here as
Fairfield, Chester, Richland, Darlington, Sumter, Florence, Dillon, Williamsburg, Georgetown,
Orangeburg, Barnwell, Allendale, Hampton, Colleton, and Bamberg Counties. Total incidence
rates and late-stage rates with percentage of AA persons per county can be found in Appendix B
in Figures 36 and 37 respectively.

Figure 14. Early-Stage Incidence Rates with African-American
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Education and Mortality
Persons having less than a high school education are at a higher risk of PrCa mortality.
The correlation value is .458 and having less education is a significant predictor of PrCa
mortality with a p value of .001. The counties highlighted are Laurens, McCormick, Saluda,
Fairfield, Marlboro, Dillon, Marion, Darlington, Lee, Clarendon, Williamsburg, Jasper,
Hampton, Colleton, Bamberg, Barnwell, and Allendale. Figure 15 shows less than a high school
education and PrCa mortality.

Figure 15. Mortality Rates with Education
Poverty and Mortality
McCormick, Fairfield, Lee, Darlington, Marion, Dillon, Marlboro, Williamsburg,
Clarendon, Orangeburg, Bamberg, Allendale, Barnwell, Colleton, Jasper, and Hampton
are the counties shown in Figure 16.
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Figure 16. Mortality Rates with Poverty
Living below the poverty line is the second most highly correlated value in Table 1 with a value
of .640. The statistical significance is .000 indicating the highest level of significance. Living
within 150% of the poverty line is also positively correlated with increased PrCa mortality at a
value of .670. The map for living within 150% of the poverty line is in Appendix B and shows
the same counties in the darkest purple except Sumter County is also highlighted in Figure 38.
Health Insurance and Mortality
A lack of health insurance is a positive predictor for PrCa mortality at a value of .622. It
is statistically significant, where the p value is .000. The counties shown in Figure 17 are Lee,
Marion, Williamsburg, Allendale, Saluda, Darlington, Marlboro, Dillon, Clarendon, Orangeburg,
Bamberg, Barnwell, Colleton, Jasper, and Hampton.

50

Figure 17. Mortality Rates with Health Insurance
Rural Versus Urban and Mortality
Persons living in urban areas are less likely to have higher rates of PrCa mortality. The
negative value of -.316 indicates that counties that are more rural have a higher likelihood of
PrCa mortality. The p value is significant at .032.
Lee, Fairfield, Saluda, McCormick, Clarendon, and Williamsburg are the brightest blue
counties on the map in Figure 18 and represent those with high PrCa mortality and low rates of
urbanization, therefore, being those that are most rural. The shading on this map is also shown in
quartiles rather than standard deviation.
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Figure 18. Mortality Rates with Rural Versus Urban
African-American and Mortality
Counties that have high percentages of AA persons have the highest predictive value of
having high rates of PrCa mortality at a value of .728. Of all of the variables considered, this is
the most predictive in Table 1. Figure 19 shows a scatterplot representing these values.

Figure 19. SingleScatterPlot with Mortality Rates and African-American
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There are 17 counties represented in Figure 20, the largest number of any of the maps
considered. The counties shown are Jasper, Hampton, Colleton, Allendale, Barnwell, Bamberg,
Orangeburg, Williamsburg, Clarendon, Sumter, Lee, Darlington, Marion, Dillon, Marlboro,
Fairfield, and McCormick.

Figure 20. Mortality Rates with African-American
White Variables Only
Of the five independent variables considered earlier (education, poverty, health
insurance, rural versus urban, and African-American), only two can be broken down into white
only. However, all of the dependent variables are available for white only comparison. Table 2
shows the correlation values along with their p values for significance. No value is significant
and therefore none of these correlation values are worth considering.
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Table 2.
White Correlation Values
N=46
Less Than a
HS Education
Income Below
the Poverty
Line

Pearson
Correlation
Significance
Pearson
Correlation

Early Stage
Incidence

Late Stage
Incidence

Total
Incidence

Mortality+

-.174

-.071

-.127

.055

.246

.638

.400

.714

-.019

.006

-.004

.082

Significance
.902
.970
.977
* indicates statistical significance at a value of p<.05
+indicates missing values were replaced with the state average

.589

See Appendix B for the maps for white only comparison in Figures 39-46.
Less Than a High School Education
For white total incidence rates there are four fewer counties highlighted than the 11
highlighted in race-adjusted incidence rates, and only five are the same. One noticeable
difference is that three of the white counties highlighted are in Appalachia; two of those do not
show up in the race-adjusted rates. The early-stage rate maps are extremely similar except the
white map has one more county than the race-adjusted and two counties are in Appalachia. The
white late-stage map is quite noticeably focused in the Appalachian region and its surrounding
counties. Only six counties are highlighted for white mortality as opposed to 16 for the raceadjusted counties. Two of the six are not on the overall map; they are Cherokee and Anderson,
both Appalachian counties.
Income Below the Poverty Line
When considering total incidence, the white rates only have six counties highlighted and
three of them are in Appalachia. The other three are also highlighted on the race-adjusted map.
The race-adjusted map has a total of 11 counties highlighted. For early-stage white incidence,
there are 10 counties highlighted versus the 11 highlighted on the race-adjusted. Again, four of
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the seven white late-stage counties are in Appalachia or touching an Appalachian county, not the
case for the race-adjusted rates. For white mortality there are only six counties as opposed to 16
for race-adjusted mortality. Five of the six white mortality highlighted counties are also on the
race-adjusted map, but one is different and that’s Cherokee.
African-American Variables Only
As with the white only variables, only education and poverty can be considered for the
independent variables and all of the incidence and mortality variables are available. Table 3
shows the correlation values along with the significant p values. Maps can be found in Appendix
B in Figures 47-54.
Table 3.
African-American Correlation Values
N=46
Early-Stage
Late-Stage
Total
Incidence
Incidence
Incidence
Less Than a
Pearson
-.381(*)
-.312(*)
-.338(*)
HS Education
Correlation
Significance
.009
.035
.022
Income Below Pearson
the Poverty
Correlation
-.053
-.026
-.075
Line
Significance
.725
.863
.621
* indicates statistical significance at a value of p<.05
+indicates missing values were replaced with the state average

Mortality+
.182
.226
.004
.979

Less Than a High School Education
All three incidence rates are significantly negatively correlated with having less than a
high school education. Therefore, the more education AA people have the more likely they are to
be diagnosed with PrCa, or more likely this means that people with more education and being
screened more often. The maps are available in Appendix B. Laurens is the only county, out of
nine, that is highlighted on the AA early-stage incidence map that is not on the race-adjusted
map, while Georgetown is the only highlighted county, of 10, on the AA late-stage incidence
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map that is not on the race-adjusted map. Georgetown, Lancaster, and Laurens appear of the AA
total incidence map and not on the race-adjusted incidence map. The other seven are the same.
For AA mortality, it is positively correlated with having less than a high school education, but it
is not significant. Chester and Lancaster are the only two counties not on the race-adjusted
mortality map that are on the AA mortality map.
Income Below the Poverty Line
Living below the poverty line is actually negatively correlated with all types of incidence
and the positive correlation with mortality may as well be zero because it is so small. However,
living below the poverty line is significantly correlated with having less than a high school
education. Florence and Horry are not on the race-adjusted map, but the rest of the highlighted
counties are for total incidence. Of the nine counties listed on the AA early-stage incidence map,
Charleston and Florence are the only two not on the race-adjusted map. For AA late-stage
incidence, Horry is the only difference. Of the six counties, Saluda is the only one highlighted on
the AA mortality map that is not on the race-adjusted map.
Screening Rates Compared to Mortality
Keeping in mind that screening rates have a low N value, and that they are only by
region, it is hard to put a lot of validity into the answer to this question. However,
the blue counties have high mortality and low screening rates, which are McCormick and Saluda.
The red county has low mortality and high screening rates which is Beaufort. Figure 21 shows
screening results from 2001. The results are not significantly correlated. Union, Lancaster, and
Oconee join Beaufort as counties with high screening rates and low mortality for 2002 (See
Figure 55 in Appendix B).
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Figure 21. Mortality Rates with 2001 Screening Rates
Incidence Compared with Mortality
Thirteen counties have high rates of total incidence as well as high rates of mortality.
Total incidence and mortality are positively correlated at a value of .329 and are significant
because p=.026. These counties, Hampton, Allendale, Barnwell, Bamberg, Colleton, Dorchester,
Berkeley, Williamsburg, Orangeburg, Sumter, Marion, Dillon, and Fairfield, are highlighted in
Figure 22. Early-stage is significantly positively correlated with mortality at a value of .305
(p=.039). However, late-stage is not significantly correlated, but it is positively. Early- and latestage maps can be seen in Appendix B (Figures 56 and 57).
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Figure 22. Mortality Rates with Late-Stage Incidence Rates
Early-Stage Rates and Late-Stage Rates
Counties that have early-stage rates are likely to have late-stage rates. The two are
significantly positively correlated at a value of .543 and a p value of .000. Sixteen counties have
both early- and late-stage rates at a high level, as seen in Figure 23. They include Greenville,
Abbeville, Chester, Fairfield, Richland, Marion, Georgetown, Williamsburg, Charleston,
Dorchester, Berkeley, Orangeburg, Colleton, Allendale, Bamberg, and Barnwell.

Figure 23. Early-Stage Incidence Rates with Late-Stage Incidence Rates
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All Independent Variables
Using the StarPlot application can help to determine which counties have high rates of all
of the independent variables. It would appear that Allendale County has the highest rates of four
of the variables excluding URBANA in Figure 24. The counties that have high percentages of all
of the variables are Dillon, Lee, Jasper, and Williamsburg. URBANA is not included in the
StarPlot but assessed in the color. Therefore, counties that are white and the lighter shades of
purple are the more rural counties.

Figure 24. StarPlot with Independent Variables
All Independent Variables with Incidence and Mortality
URBANA is represented in yellow in this map. The counties that have high rates of all of
the independent variables as well as of the high total incidence and mortality are Barnwell,
Fairfield, and Williamsburg in the most rural locations. Hampton, Colleton, Dillon, and
Orangeburg follow in the second most rural quartile as shown in Figure 25.
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Figure 25. StarPlotMap with Incidence and Mortality with Independent Variables
Consistent Counties
Table 4 shows how many times each county showed up on a map.
Table 4.
Map Appearances
County
Cherokee
Union
Chester
Fairfield
Laurens
Abbeville
McCormick
Lee
Marion
Williamsburg
Jasper
Colleton
Bamberg
Barnwell

Early-stage
Incidence

EB
EPBR
E

EHB
EPHBR
EPHB
EPHB
EPHB

Late-stage
Incidence
E
E
EB
EPBR
E
E
EPB
EPHB
EPHB
EPHB
EPHB
EPHB
EPHB
EPHBR
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Total
Incidence
E
EB
EPBR

EPHBR
EPHB
EPHB
EPHB

Mortality

EPBR
E
EPB
EPHBR
EPHB
EPHBR
EPHB
EPHB
EPHB
EPHB

Total
2
1
6
16
2
2
6
9
11
19
8
16
16
17

Sig.

1
7
1
4
6
7
9
5
8
8
8

Table 4 (cont).
Map Appearances
County

Early-stage
Incidence
EPHB
EPHB
EPHB
P

Late-stage
Incidence
EPHB

Total
Incidence
EPHB

Mortality

Total

Sig.

Allendale
EPHB
16
8
Darlington
EPHB
8
5
Dillon
EPHB
EPHB
12
8
Marlboro
EPHB
EPHB
9
8
Hampton
EPHB
EPHB
8
8
Saluda
EHR
3
3
Clarendon
EPHBR 5
5
Orangeburg
PHB
PHB
PHB
PHB
12
7
Georgetown
PHB
PHB
PHB
9
4
Sumter
B
B
B
3
3
Richland
B
B
2
1
Florence
B
B
2
2
E is for Less Than a High School Education, P is for Living Below the Poverty Line, H is for
No Health Insurance, B is for Black, and R is for Rural

Williamsburg appeared on the most maps with a total of 19. Barnwell was the second
highest with 17, followed by four counties that had 16 which were Allendale, Bamberg,
Colleton, and Fairfield. The next closest set of counties totals 12, four less.
When only considering counties where the correlation value was significant the total is
nine maps and Williamsburg County is the only one to appear on all nine. Seven counties appear
on eight maps which are Colleton, Bamberg, Barnwell, Allendale, Dillon, Marlboro, and
Hampton. Orangeburg, Marion, and Fairfield counties each appear on seven of the nine maps.
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CHAPTER 5
DISCUSSION
Attacking PrCa is complicated due to so many uncertainties of the disease. Is screening
asymptomatic men effective? Does it do more harm than good? Yet, as previously mentioned
PrCa is the second leading cancer killer of men in South Carolina (Center for Disease Control
and Prevention, 2007). The following are recommendations based on the findings of this study as
to possible areas of increased need of PrCa intervention.
Consistent Counties
While analyzing all of the independent variables, compared with the dependent variables,
20 maps were created. The number of times that each county appeared on one of these maps was
totaled to use as a comparison for which counties are in the greatest need of an intervention.
Williamson County appeared on 19 of the 20 maps. Barnwell County appeared the second
highest number of times totaling 17. Four other counties appeared 16 times each, Allendale,
Bamberg, Colleton, and Fairfield. The next closest number was only 12; therefore, these were
not considered to be of the highest priority for this classification and not included on the map in
Figure 26. Of the six counties that
showed up on most of the maps,
they are in five different regional
health districts. This does not make
a plan for implementing an
intervention by district very easy.
However, collaboration through
some of the counties could

Figure 26. Consistent Counties
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increase the possibility because four of the six counties are situated in the same area and are all
connected to each other.
Correlations
The correlation values in Table 1 did reflect, for the most part, what this author thought
as well as previous literature. However, the values were not nearly as high as expected and only
nine of the 20 analyses were statistically significant at p<.05. Due to this fact, and only
considering the significantly correlated values, only nine of the maps are taken into
consideration, when previously the total possible of appearing on maps was 20. This would take
into account all five independent variables compared with mortality, total incidence compared
with less than a high school education, no health insurance, and a high percent of AA people per
county, and AA compared with early-stage incidence. If this is the case, Williamsburg still has
the highest total with all nine. However, the number of counties in need does increase from six to
11 that have high numbers of appearances that are grouped together. The counties that are added
that did not appear before were Dillon, Marlboro, Hampton, Orangeburg, and Marion, showing a
greater need for some type of intervention in the southern area of the state. Figure 27 shows how
there are two counties that are of
concern, Fairfield and Williamsburg
that are not with any of the other
counties. This is also true of regional
health districts. Fairfield and
Williamsburg are the only ones that
are in their district. Marlboro, Dillon,
and Marion are all in the same region,

Figure 27. Correlation Consistent Counties
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the Pee Dee region, and perhaps focusing a plan at the regional level could be beneficial and the
same personnel could work on one project. The six counties that are located in the southern part
of the state reside in three different districts. If the decision was made to plan for interventions at
the regional level some resource allocation could occur because all 11 of the counties are in six
regions, rather than having to budget for all 13 regions. This could cut down on more than half
the costs or more funding could go to the areas in greater need.
African-American Versus White
When considering AA rates versus white rates, the main difference is that higher white
rates are associated with Appalachian counties. However, in those counties the AA rates are still
higher than the white rates. Once again, this shows a need to focus on counties with higher rates
of AA men because they are more likely to be affected by PrCa. The AA incidence rates are
significantly negatively correlated with having less than a high school education (p=.009, .035,
and .022 respectively for early-stage, late-stage, and total incidence rates). This indicates that AA
men who are more educated are the ones being screened. Focusing in areas where there are low
screening rates and high rates of AA people with less than a high school education would be one
way to plan an intervention. Figure 58 highlights four counties (Abbeville, Chesterfield, Saluda,
and McCormick), three of which are in the same district (See Appendix B). While screening
rates are calculated by region, this author advises putting more educational emphasis with
regards to PrCa screening into the Upper Savannah region than into any of the others because
this is the area where the lowest screening rates occur and have the highest rates of AA persons
with less than a high school education. The Upper Savannah region includes Abbeville,
Edgefield, Greenwood, Laurens, McCormick, and Saluda counties.
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Access Versus Screening
Bamberg County has high rates of no health insurance and low rates of screening. Using
quartiles as the distributing factor, it is the only county in the lowest quartile for screening and
the highest quartile for a lack of health insurance. While more than likely the need for increased
health insurance will happen on a state-wide level, a county specific plan would be beneficial,
especially because this county has high rates of all types of PrCa, early-stage, late-state, total
incidence, and mortality. Therefore, men are being screened, but they are also dying. An increase
in health insurance or access to treatment could decrease these rates.
Late-Stage Incidence Versus Mortality
Areas with both high rates of late-stage incidence and high rates of mortality indicate an
added need for intervention. The counties that have both are McCormick, Fairfield, Marion,
Orangeburg, Colleton, and Bamberg. These areas are in greater need of screening. Once men
have been diagnosed, those with lower incomes will need a means of treating their disease. This
is where policymakers can help find ways of funding treatment. While policymakers did increase
access to screening for breast and cervical, there is currently not a means for increased PrCa
screening (Drake et al., 2006).
Early Detection Objective 4 SCCA CA Plan
In order to increase the percent of diagnosis from 72.6% to at least 75% for early-stage
diagnosis, increased screening activities should be focused on areas with higher rates of latestage diagnosis. Colleton County has the highest rates per 100,000 of late-stage incidence, yet it
also has high rates of PrCa screening. Bamberg and Orangeburg also have high rates of late-stage
incidence but are in the lowest quartile for screening. Attempting to increase screening in
Bamberg and Orangeburg would be advisable first. However, increased screening will increase
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incidence rates. Focusing on counties that have high mortality rates but low incidence rates could
help to obtain this objective. These counties are Hampton, Jasper, Clarendon, Lee, Kershaw,
Marlboro, Saluda, and McCormick.
Another way to look at obtaining this objective would be to focus in counties that have
high rates of late-stage incidence but not high rates of early-stage incidence. These counties
include Greenville, McCormick, Chester, Marion, Georgetown, and Barnwell.
Early Detection Objective 5 SCCA CA Plan
The need to raise men’s awareness about PrCa screening is complicated. Focusing in
areas where there are low screening rates and high rates of mortality is this author’s
recommendation. These areas are McCormick County and Saluda County. They are the only two
counties that are in the lowest quartile of screening rates and the highest quartile of PrCa
mortality. Screening rates are, however, by regional health district. This indicates, once again,
focusing in the Upper Savannah district. A comprehensive plan to educate men as to their need
to know about what’s best for them and screening is imperative. The CDC created screening
guides especially for AA men, perhaps putting those in locations that are easily accessible could
be a start to education.
Advocacy and Policy Objective 3 SCCA CA Plan
The strategy for this plan is at a state-wide level. The counties that have the highest rates
of no health insurance are mostly those that also fall under the consistent counties discussed
earlier and shown on the map in Figure 27 (See Appendix B). The consistent counties are those
that show up on the maps again and again, no matter what variables are being considered. Breast
and cervical cancer have had a successful plan that the state supported, but as previously
mentioned, this could be expanded to other cancers and screening plans.
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Challenges
Many challenges arise with a new program. First learning to use it will be difficult.
Beyond that communicating and disseminating complicated disease information is always a
complex process. However, time and experience will make it better and easier. Finding the right
personnel to use and interpret the software could impede the process. The biggest challenge will
be remembering that visualization software is a means of interpreting the data and not the only
way (Anselin, 2006).
Overall Recommendations
The first decision that policy makers have to make is what they plan to focus on. For
instance, if they plan to make state-wide changes versus only focusing in areas of greater need or
if they plan to focus on incidence, mortality, etc. Once this decision has been made, using the
GeoViz Toolkit becomes easier because they will know what they are looking for. As previous
authors have mentioned, using mapping software can show areas in higher need, but without
direction, the effort can become futile. Recommendations have been made throughout this
section as to possible focus areas, but the priority chosen by the policy makers will determine
which counties to focus on and where resources should be spent.
Benefits to Health Services Administration
Using the GeoViz Toolkit could help to reduce the cancer burden. Identifying those areas
in need could increase the ability to allocate resources rather than having to disperse them all
over the state and could focus funds into certain areas. Also, decreasing the prevalence of any
disease would decrease the costs on the health care system. This program could be used for any
cancer or other disease with the right data. PrCa is merely one example and only the beginning.
This program also allows identification of areas that are lacking in certain resources, such as
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mapping areas with low health insurance, low screening rates, etc. The benefits for policy
makers follow along the same lines.
Limitations of This Study
Several limitations of this study occurred throughout the progress. One limitation was the
time of the author and obtaining information from persons in South Carolina with direct
knowledge of the activities of the Prostate Cancer Task Force. Another limitation was access and
permission to PrCa data on an individual level due to restrictions on confidentiality from both the
IRB and the South Carolina Central Cancer Registries Policies. Therefore, having to use county
level data does require making a lot of assumptions, such that it is actually the people who are
getting PrCa that have low income, less than a high school education, are AA, live in rural areas,
and do not have insurance.
As the GeoViz Toolkit is a work in progress, several problems occurred during its use.
One of these problems was the inability of the scatterplot function to match the correlation
values of SPSS. This could very well have been a user error, but this author was unable to
determine the cause of the disagreement. Another issue was the inability to load the data. Not
knowing or having a GIS program in which a shapefile could be created, the data always had to
be sent to someone at the South Carolina Department of Health and Environmental Control
office. While the shapefile was always returned in a timely fashion, the process no doubt slowed
the results. An easier interface for uploading data would make the process of analysis easier.
Future Recommendations
In future studies about PrCa in South Carolina, age should be considered. It was not a
part of this study and the counties in need may vary due to where younger persons are being
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diagnosed because PrCa will more than likely effect most men to some degree, if they live long
enough.
Individual data could possibly produce more conclusive results. This study analyzed data
at the county level. It is possible that the persons who die from PrCa are not the ones who have
low income, are undereducated, etc. Even though it is highly unlikely based on previous
literature, it would still produce more convincing evidence of a need for an intervention.
However, an analysis similar to this one could be done, if this software were in the hands of
people who have access to individual level data.
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CHAPTER 6
CONCLUSION
Spatial visualization is a useful tool for informing cancer control policy. Presenting
complicated disease control information in any format is not easy. However, presenting
information about a program that is new to many of the people is even more complicated. The
GeoViz Toolkit is a complicated and not always user-friendly program, but with the right
personnel and a little training, could be extremely useful for identifying areas of increased need
of intervention. Comprehensive Cancer Control agencies would benefit fully from its use and,
therefore, so could the populations in which the high disparities of PrCa incidence and mortality
occur.
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APPENDICES
APPENDIX A
Coded Variables
Variable
Total PrCa Incidence from 1997-2003
Early-stage PrCa Incidence from 1997-2003
Late-stage PrCaIncidence from 1997-2003
PrCa Mortality from 1997-2003
Total Cancer Mortality 1997-2003
Less Than a High School Education 2000
Income Below the Poverty Line 2000
Income Within 150% of the Poverty Line 2000
African-American Persons Living in a County 2000
Rural Versus Urban 2000
No Health Insurance 2000
White Less than a High School Education 2000
African-American Less than a High School Education 2000
White Income Below the Poverty Line 2000
White Income Within 150% of the Poverty Line 2000
African-American Income Below the Poverty Line 2000
African-American Income Within 150% of the Poverty Line 2000
PrCa Screening Rates 2001
PrCa Screening Rates 2002
Infant Mortality Rates 2000
White Total PrCa Incidence from 1997-2003
White Early-Stage PrCa Incidence from 1997-2003
White Late-Stage PrCa Incidence from 1997-2003
White PrCa Mortality from 1997-2003
African-American Total PrCa Incidence from 1997-2003
African-American Early-stage PrCa Incidence from 1997-2003
African-American Late-stage PrCa Incidence from 1997-2003
African-American PrCa Mortality from 1997-2003
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Coded As:
R_ALL_97_03
R_ALL_EARLY
R_ALL_LATE
AAPM
AAAM
LTHEDA
PLTCPOVA
PLTCVPOVA
BLACK
URBANA
HI
LTHEDW
LTHEDB
PLTCPOVW
PLTCVPOVW
PLTCPOVB
PLTCVPOVB
PCSR01
PCSR02
IMR2000
R_W_97_03
R_W_EARLY
R_W_LATE
AAWPM_2
R_B_97_03
R_B_EARLY
R_B_LATE
AABPM_2

APPENDIX B
Maps

Figure 28. Early-Stage Incidence Rates with Education
Counties highlighted: Barnwell, Allendale, Colleton, Bamberg, Williamsburg, Marion, Dillon,
Darlington, Fairfield, Chester, and Abbeville

Figure 29. Total Incidence Rates with Education
Counties highlighted: Cherokee, Chester, Fairfield, Marlboro, Dillon, Williamsburg, Barnwell,
Bamberg, Colleton, Allendale, and Hampton
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Figure 30. Early-Stage Incidence Rates with Poverty
Counties highlighted: Barnwell, Allendale, Bamberg, Colleton, Orangeburg, Fairfield,
Darlington, Dillon, Marion, Williamsburg, and Georgetown

Figure 31. Late-Stage Incidence Rates with Poverty
Counties highlighted: McCormick, Fairfield, Lee, Marion, Georgetown, Williamsburg,
Orangeburg, Bamberg, Colleton, Jasper, Allendale, and Barnwell
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Figure 32. Early-Stage Incidence Rates with Health Insurance
Counties highlighted: Allendale, Barnwell, Bamberg, Colleton, Orangeburg, Williamsburg,
Georgetown, Marion, Dillon, and Darlington

Figure 33. Late-Stage Incidence Rates with Health Insurance
Counties highlighted: Jasper, Colleton, Allendale, Barnwell, Bamberg, Orangeburg,
Williamsburg, Georgetown, Marion, and Lee
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Figure 34. Early-Stage Incidence Rates with Rural Versus Urban
Counties highlighted: Fairfield, and Williamsburg

Figure 35. Late-Stage Incidence Rates with Rural Versus Urban
Counties highlighted: Fairfield, McCormick, and Barnwell
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Figure 36. Total Incidence Rates with African-American
Counties highlighted: Orangeburg, Bamberg, Barnwell, Allendale, Hampton, Colleton, Sumter,
Georgetown, Florence, Dillon, Marlboro, Chester Williamsburg, and Fairfield

Figure 37. Late-Stage Incidence Rates with African-American
Counties highlighted: McCormick, Jasper, Colleton, Allendale, Barnwell, Bamberg, Orangeburg,
Richland, Fairfield, Chester, Lee, Marion, Williamsburg, and Georgetown
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Figure 38. Mortality Rates with 150% of Poverty Line
Counties highlighted: Jasper, Hampton, Colleton, Barnwell, Bamberg, Orangeburg, Sumter, Lee,
Darlington, Allendale, Clarendon, Williamsburg, Dillon, Marlboro, Fairfield, McCormick, and
Marion

Figure 39. White Total Incidence Rates with White Education
Counties highlighted: Oconee, Pickens, Cherokee, Marlboro, Chester, Bamberg, and Colleton
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Figure 40. White Early-Stage Incidence Rates with White Education
Counties highlighted: Pickens, Anderson, Abbeville, Chester, Fairfield, Darlington, Marlboro,
Dillon, Barnwell, Colleton, and Bamberg

Figure 41. White Late-Stage Incidence Rates with White Education
Counties highlighted: Oconee, Pickens, Anderson, Laurens, Spartanburg, Cherokee, Union,
Chester, Saluda, Bamberg, and Colleton
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Figure 42. White Mortality Rates with White Education
Counties highlighted: Anderson, Cherokee, Marlboro, Darlington, Marion, and Colleton

Figure 43. White Total Incidence Rates with Poverty
Counties highlighted: Oconee, Pickens, Cherokee, Marlboro, Bamberg, and Colleton
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Figure 44. White Early-Stage Incidence Rates with Poverty
Counties highlighted: Barnwell, Bamberg, Colleton, Clarendon, Darlington, Marlboro, Dillon,
Abbeville, Fairfield, and Pickens

Figure 45. White Late-Stage Incidence Rates with Poverty
Counties highlighted: Allendale, Bamberg, Colleton, Laurens, Cherokee, Pickens, and Oconee
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Figure 46. White Mortality Rates with White Poverty
Counties highlighted: Colleton, Clarendon, Marion, Darlington, Marlboro, and Cherokee

Figure 47. African-American Total Incidence Rates with African-American Education
Counties highlighted: Colleton, Bamberg, Williamsburg, Georgetown, Dillon, Marlboro,
Lancaster, Chester, Fairfield, and Laurens
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Figure 48. African-American Early-Stage Incidence Rates with African-American Education
Counties highlighted: Abbeville, Laurens, Chester, Fairfield, Darlington, Williamsburg,
Georgetown, Colleton, and Bamberg

Figure 49. African-American Late-Stage Incidence Rates with African-American Education
Counties highlighted: Jasper, Colleton, Bamberg, Barnwell, Williamsburg, Georgetown,
Fairfield, Chester, Laurens, and Abbeville
96

Figure 50. African-American Mortality Rates with African-American Education
Counties highlighted: Hampton, Barnwell, Lee, Williamsburg, Dillon, Chester, Fairfield,
Laurens, Saluda, and Lancaster

Figure 51. African-American Total Incidence Rates with African-American Poverty
Counties highlighted: Colleton, Bamberg, Orangeburg, Williamsburg, Georgetown, Horry,
Florence, Dillon, and Marlboro
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Figure 52. African-American Early-Stage Incidence Rates with African-American Poverty
Counties highlighted: Charleston, Colleton, Bamberg, Orangeburg, Georgetown, Williamsburg,
Marion, Florence, and Darlington

Figure 53. African-American Late-Stage Incidence Rates with African-American Poverty
Counties highlighted: Hampton, Colleton, Barnwell, Bamberg, Orangeburg, Williamsburg,
Georgetown, Marion, and Horry
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Figure 54. African-American Mortality Rates with African-American Poverty
Counties highlighted: Hampton, Barnwell, Williamsburg, Lee, Saluda, and Dillon

Figure 55. Mortality Rates with 2002 Screening Rates
Counties highlighted with low screening rates and high mortality: McCormick and Saluda
Counties highlighted with high screening rates and low mortality: Beaufort, Oconee, Union, and
Lancaster
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Figure 56. Mortality Rates and Early-Stage Incidence Rates
Counties highlighted: Allendale, Barnwell, Colleton, Bamberg, Orangeburg, Dorchester,
Berkeley, Williamsburg, Sumter, Fairfield, Darlington, Marion, and Dillon

Figure 57. Mortality Rates and Late-Stage Incidence Rates
Counties highlighted: Jasper, Colleton, Dorchester, Berkeley, Williamsburg, Orangeburg,
Bamberg, Allendale, Barnwell, Lee, Marion, McCormick, Fairfield, and Laurens
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Figure 58. African-American Education with 2001 Screening Rates
Counties highlighted: Abbeville, McCormick, Saluda, and Chesterfield
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